Dr.Subekshya Khadka

Research Fellow, Critical Care Medicine|ACRC| Mayo Clinic, Florida|Equity and Peace

[Dr.Subekshya Khadka @Subeksh25086204]

@tulmayaa 15 lakh chodera kata yeta ako dd

[Dr.Subekshya Khadka @Subeksh25086204]

@DrDanMO @pkguru10 🙏

[Dr.Subekshya Khadka @Subeksh25086204]

@tulmayaa 🥲🥲😭

[Shahin Isha @i_sha_hin]

Lessons that are not included in any curriculum. (1/2)
Source: social media
#MedTwitter

[Dr.Subekshya Khadka @Subeksh25086204]

@tulmayaa Yo sis

[Dr.Subekshya Khadka @Subeksh25086204]

@parthsatashia94 @Dev_Sanghavi @pmorenofranco @i_sha_hin @AmerMedicalAssn @MCFACRC @MayoMrfa Congratulations to the team! Congratulations brother

[Dr.Subekshya Khadka @Subeksh25086204]

@tulmayaa Yesss

[Dr.Subekshya Khadka @Subeksh25086204]

@Sedhai007 Dai even i was thinking your first name as Yub ! Thankyou for the clarification 🤗

[Dr.Subekshya Khadka @Subeksh25086204]

Thankyou ACRC critical care Department for this once in a lifetime opportunity! This embarks my new journey.
Will always& forever be greatful ♡

[Dr.Subekshya Khadka @Subeksh25086204]

@i_sha_hin @Toastmasters Would love to bea a part of it

[Dr.Subekshya Khadka @Subeksh25086204]

@tulmayaa 😇

[Dr.Subekshya Khadka @Subeksh25086204]

@tulmayaa Haha hahaa,

[Dr.Subekshya Khadka @Subeksh25086204]

@shivangb25_2 @Dr_shahin_isha @JacobiHosp Congratulations shivang and best wishes !

[Dr.Subekshya Khadka @Subeksh25086204]

@omar_danoun @DrSakhii Wow😮

[Dr.Subekshya Khadka @Subeksh25086204]

@tulmayaa Haha

[Dr.Subekshya Khadka @Subeksh25086204]

@dryashbhattarai I wish the same for you yash!

[Dr.Subekshya Khadka @Subeksh25086204]

@tulmayaa Hiiiiiiiiiii

[Dr.Subekshya Khadka @Subeksh25086204]

@tulmayaa Safe travels di

[NPR @NPR]

A trial group of people with rectal cancer just experienced something of a scientific miracle: their cancer vanished after an experimental treatment.

Patients took a drug called dostarlimab for six months which resulted in their tumors disappearing. https://t.co/LvuNvE4LnW

[Parveen Kaswan, IFS @ParveenKaswan]

To the point.